Hyperglycemia Induces Toll-Like Receptor Activity Through Increased Oxidative Stress

Roma Pahwa, Ishwarlal Jialal

Research output: Contribution to journalReview article

10 Citations (Scopus)

Abstract

Hyperglycemia-induced oxidative stress and inflammation are central in the genesis of diabetic vascular complications. Toll-like receptors (TLRs) play a crucial role in promoting inflammatory responses and are known to be activated in diabetic patients. Also in animal models, they have been shown to have a role in the pathogenesis of diabetic vasculopathies. However, the mechanisms underlying this increase in TLR activity in diabetes are not well documented. Since increased reactive oxygen species (ROS) are also produced in various tissues under diabetic conditions, we postulated that ROS act as a potential activator of TLR. Several studies support our hypothesis that hyperglycemia-induced oxidative stress appears to be an important factor in promoting TLR activity in monocytes, both microvascular and macrovascular endothelial cells and cardiomyocytes and in animal models. Most importantly, the increase in ROS and TLR activity is ameliorated with antioxidant strategies. Thus, targeting ROS/NADPH oxidase with small molecular inhibitors could be a promising strategy to reduce both oxidative stress and TLR-mediated inflammation in diabetic vascular diseases.

Original languageEnglish (US)
Pages (from-to)239-241
Number of pages3
JournalMetabolic Syndrome and Related Disorders
Volume14
Issue number5
DOIs
StatePublished - Jun 1 2016

Fingerprint

Toll-Like Receptors
Hyperglycemia
Oxidative Stress
Reactive Oxygen Species
Diabetic Angiopathies
Animal Models
Inflammation
NADPH Oxidase
Cardiac Myocytes
Monocytes
Endothelial Cells
Antioxidants

ASJC Scopus subject areas

  • Endocrinology, Diabetes and Metabolism
  • Internal Medicine

Cite this

Hyperglycemia Induces Toll-Like Receptor Activity Through Increased Oxidative Stress. / Pahwa, Roma; Jialal, Ishwarlal.

In: Metabolic Syndrome and Related Disorders, Vol. 14, No. 5, 01.06.2016, p. 239-241.

Research output: Contribution to journalReview article

@article{746faef16d3f4604881c365a58c0f951,
title = "Hyperglycemia Induces Toll-Like Receptor Activity Through Increased Oxidative Stress",
abstract = "Hyperglycemia-induced oxidative stress and inflammation are central in the genesis of diabetic vascular complications. Toll-like receptors (TLRs) play a crucial role in promoting inflammatory responses and are known to be activated in diabetic patients. Also in animal models, they have been shown to have a role in the pathogenesis of diabetic vasculopathies. However, the mechanisms underlying this increase in TLR activity in diabetes are not well documented. Since increased reactive oxygen species (ROS) are also produced in various tissues under diabetic conditions, we postulated that ROS act as a potential activator of TLR. Several studies support our hypothesis that hyperglycemia-induced oxidative stress appears to be an important factor in promoting TLR activity in monocytes, both microvascular and macrovascular endothelial cells and cardiomyocytes and in animal models. Most importantly, the increase in ROS and TLR activity is ameliorated with antioxidant strategies. Thus, targeting ROS/NADPH oxidase with small molecular inhibitors could be a promising strategy to reduce both oxidative stress and TLR-mediated inflammation in diabetic vascular diseases.",
author = "Roma Pahwa and Ishwarlal Jialal",
year = "2016",
month = "6",
day = "1",
doi = "10.1089/met.2016.29006.pah",
language = "English (US)",
volume = "14",
pages = "239--241",
journal = "Metabolic Syndrome and Related Disorders",
issn = "1540-4196",
publisher = "Mary Ann Liebert Inc.",
number = "5",

}

TY - JOUR

T1 - Hyperglycemia Induces Toll-Like Receptor Activity Through Increased Oxidative Stress

AU - Pahwa, Roma

AU - Jialal, Ishwarlal

PY - 2016/6/1

Y1 - 2016/6/1

N2 - Hyperglycemia-induced oxidative stress and inflammation are central in the genesis of diabetic vascular complications. Toll-like receptors (TLRs) play a crucial role in promoting inflammatory responses and are known to be activated in diabetic patients. Also in animal models, they have been shown to have a role in the pathogenesis of diabetic vasculopathies. However, the mechanisms underlying this increase in TLR activity in diabetes are not well documented. Since increased reactive oxygen species (ROS) are also produced in various tissues under diabetic conditions, we postulated that ROS act as a potential activator of TLR. Several studies support our hypothesis that hyperglycemia-induced oxidative stress appears to be an important factor in promoting TLR activity in monocytes, both microvascular and macrovascular endothelial cells and cardiomyocytes and in animal models. Most importantly, the increase in ROS and TLR activity is ameliorated with antioxidant strategies. Thus, targeting ROS/NADPH oxidase with small molecular inhibitors could be a promising strategy to reduce both oxidative stress and TLR-mediated inflammation in diabetic vascular diseases.

AB - Hyperglycemia-induced oxidative stress and inflammation are central in the genesis of diabetic vascular complications. Toll-like receptors (TLRs) play a crucial role in promoting inflammatory responses and are known to be activated in diabetic patients. Also in animal models, they have been shown to have a role in the pathogenesis of diabetic vasculopathies. However, the mechanisms underlying this increase in TLR activity in diabetes are not well documented. Since increased reactive oxygen species (ROS) are also produced in various tissues under diabetic conditions, we postulated that ROS act as a potential activator of TLR. Several studies support our hypothesis that hyperglycemia-induced oxidative stress appears to be an important factor in promoting TLR activity in monocytes, both microvascular and macrovascular endothelial cells and cardiomyocytes and in animal models. Most importantly, the increase in ROS and TLR activity is ameliorated with antioxidant strategies. Thus, targeting ROS/NADPH oxidase with small molecular inhibitors could be a promising strategy to reduce both oxidative stress and TLR-mediated inflammation in diabetic vascular diseases.

UR - http://www.scopus.com/inward/record.url?scp=84971265461&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84971265461&partnerID=8YFLogxK

U2 - 10.1089/met.2016.29006.pah

DO - 10.1089/met.2016.29006.pah

M3 - Review article

C2 - 27105077

AN - SCOPUS:84971265461

VL - 14

SP - 239

EP - 241

JO - Metabolic Syndrome and Related Disorders

JF - Metabolic Syndrome and Related Disorders

SN - 1540-4196

IS - 5

ER -